Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:29 pm Sale | 2025-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Commodore Capital LP | 1,475,000 1.400% | -4,225,000 (-74.12%) | Filing History |
| 2026-02-13 6:11 pm Purchase | 2025-01-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Vivo Opportunity Fund Holdings, L.P. | 2,700,615 2.500% | 2,700,615 (New Position) | Filing History |
| 2026-02-13 08:52 am Sale | 2025-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 3,150,000 2.970% | -4,345,000 (-57.97%) | Filing History |
| 2026-02-12 5:01 pm Sale | 2025-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Soleus Capital Master Fund, L.P. | 212,710 0.200% | -7,929,790 (-97.39%) | Filing History |
| 2026-02-12 09:14 am Purchase | 2025-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Adage Capital Management, L.P. | 5,550,000 5.100% | 5,550,000 (New Position) | Filing History |
| 2025-11-14 4:51 pm Purchase | 2025-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Commodore Capital LP | 5,700,000 6.500% | 1,050,000 (+22.58%) | Filing History |
| 2025-11-05 4:13 pm Sale | 2025-11-03 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 4,240,068 4.800% | -3,322,903 (-43.94%) | Filing History |
| 2025-10-31 11:31 am Purchase | 2025-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | The Vanguard Group | 4,559,917 5.210% | 4,559,917 (New Position) | Filing History |
| 2025-09-16 6:00 pm Purchase | 2025-09-09 | 13G | Terns Pharmaceuticals, Inc. TERN | Commodore Capital LP | 4,650,000 5.300% | 4,650,000 (New Position) | Filing History |
| 2025-08-14 08:51 am Purchase | 2025-06-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 7,495,000 8.580% | 1,918,442 (+34.40%) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Schonfeld Strategic Advisors LLC | 4,305,204 4.930% | -929,304 (-17.75%) | Filing History |
| 2025-05-15 08:47 am Sale | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 5,576,558 6.390% | -523,442 (-8.58%) | Filing History |
| 2025-05-07 11:29 am Purchase | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | MORGAN STANLEY MS | 7,099,954 8.100% | 7,099,954 (New Position) | Filing History |
| 2025-02-14 6:25 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Citadel Advisors LLC | 3,465,307 4.100% | 54,543 (+1.60%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Schonfeld Strategic Advisors LLC | 5,234,508 6.160% | 5,234,508 (New Position) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Soleus Capital Master Fund, L.P. | 8,142,500 9.600% | 1,918,956 (+30.83%) | Filing History |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 5,743,482 6.800% | 1,044,711 (+22.23%) | Filing History |
| 2024-11-15 10:35 am Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 2,894,093 3.500% | -1,027,133 (-26.19%) | Filing History |
| 2024-11-14 7:00 pm Purchase | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Vivo Capital Fund VIII L.P. | 4,597,243 5.400% | 4,597,243 (New Position) | Filing History |
| 2024-11-14 5:51 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 3,516,889 4.990% | -980,228 (-21.80%) | Filing History |